AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
31 Aug 2011 05:30 PM
RNS
Director/PDMR Shareholding
31 Aug 2011 03:40 PM
RNS
Sale of AstraTech to DENTSPLY complete
31 Aug 2011 07:00 AM
RNS
Transaction in Own Shares
30 Aug 2011 05:30 PM
RNS
Director/PDMR Shareholding
30 Aug 2011 07:00 AM
RNS
Transaction in Own Shares
26 Aug 2011 04:00 PM
RNS
Share Repurchase Programme
26 Aug 2011 07:00 AM
RNS
Transaction in Own Shares
25 Aug 2011 07:00 AM
RNS
Transaction in Own Shares
24 Aug 2011 08:30 AM
RNS
Block Listing Application
24 Aug 2011 07:00 AM
RNS
Transaction in Own Shares
23 Aug 2011 07:00 AM
RNS
Transaction in Own Shares
22 Aug 2011 07:00 AM
RNS
Transaction in Own Shares
19 Aug 2011 07:00 AM
RNS
Transaction in Own Shares
18 Aug 2011 07:00 AM
RNS
Transaction in Own Shares
17 Aug 2011 07:00 AM
RNS
Transaction in Own Shares
15 Aug 2011 07:00 AM
RNS
Transaction in Own Shares
12 Aug 2011 04:30 PM
RNS
Director/PDMR Shareholding
12 Aug 2011 07:00 AM
RNS
Transaction in Own Shares
11 Aug 2011 07:00 AM
RNS
Transaction in Own Shares
10 Aug 2011 04:00 PM
RNS
Director/PDMR Shareholding
10 Aug 2011 07:00 AM
RNS
Transaction in Own Shares
09 Aug 2011 07:00 AM
RNS
Transaction in Own Shares
08 Aug 2011 07:00 AM
RNS
Transaction in Own Shares
05 Aug 2011 07:00 AM
RNS
Transaction in Own Shares
04 Aug 2011 07:00 AM
RNS
Transaction in Own Shares
03 Aug 2011 07:00 AM
RNS
Transaction in Own Shares
02 Aug 2011 07:00 AM
RNS
Transaction in Own Shares
01 Aug 2011 03:00 PM
RNS
Total Voting Rights
01 Aug 2011 07:00 AM
RNS
Transaction in Own Shares
29 Jul 2011 07:00 AM
RNS
Transaction in Own Shares
28 Jul 2011 07:00 AM
RNS
Second Quarter Results 2011 - Part 3 of 3
28 Jul 2011 07:00 AM
RNS
Second Quarter Results 2011 - Part 2 of 3
28 Jul 2011 07:00 AM
RNS
Second Quarter Results 2011 - Part 1 of 3
28 Jul 2011 07:00 AM
RNS
Transaction in Own Shares
27 Jul 2011 09:00 AM
RNS
Notice of Results
27 Jul 2011 07:00 AM
RNS
Transaction in Own Shares
26 Jul 2011 07:00 AM
RNS
Transaction in Own Shares
25 Jul 2011 07:00 AM
RNS
Transaction in Own Shares
22 Jul 2011 07:00 AM
RNS
Transaction in Own Shares
21 Jul 2011 07:00 AM
RNS
FDA approves Brilinta for use in the US
21 Jul 2011 07:00 AM
RNS
Transaction in Own Shares
20 Jul 2011 07:00 AM
RNS
FDA advisors make recommendation on dapagliflozin
20 Jul 2011 07:00 AM
RNS
Transaction in Own Shares
19 Jul 2011 07:00 AM
RNS
Transaction in Own Shares
18 Jul 2011 07:00 AM
RNS
Transaction in Own Shares
15 Jul 2011 07:00 AM
RNS
Transaction in Own Shares
14 Jul 2011 07:00 AM
RNS
Transaction in Own Shares
13 Jul 2011 07:00 AM
RNS
Transaction in Own Shares
12 Jul 2011 07:00 AM
RNS
Transaction in Own Shares
11 Jul 2011 07:00 AM
RNS
Transaction in Own Shares

AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.

It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.

Astra Zeneca share price launched at 605p in 1993.

UK 100